|Bid||57.55 x 1400|
|Ask||57.88 x 1800|
|Day's Range||56.75 - 58.43|
|52 Week Range||45.76 - 68.34|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020|
|Forward Dividend & Yield||1.80 (3.06%)|
|Ex-Dividend Date||Oct 01, 2020|
|1y Target Est||73.19|
The Zacks Analyst Blog Highlights: Thermo Fisher, SAP, BMY, NextEra and Morgan Stanley
Bristol Myers (BMY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With interest rates on fixed income investments such as treasuries and corporate bonds at rock-bottom lows, you might expect investors to flock to dividend stocks as income sources. For investors who like bargains, that means opportunity. When they do, stock pickers who were willing to buck the trend will likely end up with handsome capital gains to go along with a steady stream of dividend income for years.